Document Detail


Antithromboxane drug in the treatment of preeclampsia.
MedLine Citation:
PMID:  1756996     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this study, we present our initial trials in the treatment of 6 cases of severe preeclampsia with thromboxane synthetase inhibitor (OKY-046). Following the treatment with OKY-046, maternal systolic blood pressure decreased significantly and umbilical artery waveforms were normalized. These data suggest that thromboxane synthetase inhibition might have a beneficial effect on preeclampsia.
Authors:
N Furuhashi; M Tsujiei; H Kimura; K Okamura; A Yajima
Related Documents :
22955146 - Tibiofemoral contact mechanics following posterior root of medial meniscus tear, repair...
2206066 - Effect of tocolytic agents on fetal umbilical velocimetry.
104276 - The flow resistance of the spiral artery and the related intervillous space in the rhes...
3618666 - Fetal monitoring during emergency obstetric transport.
32946 - Prevention and reversal of isolation-induced systolic arterial hypertension in rats by ...
20504316 - Soybean oil increases serca2a expression and left ventricular contractility in rats wit...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Gynecologic and obstetric investigation     Volume:  32     ISSN:  0378-7346     ISO Abbreviation:  Gynecol. Obstet. Invest.     Publication Date:  1991  
Date Detail:
Created Date:  1992-02-06     Completed Date:  1992-02-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7900587     Medline TA:  Gynecol Obstet Invest     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  164-6     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Drug Evaluation
Female
Humans
Methacrylates / therapeutic use*
Pre-Eclampsia / drug therapy*
Pregnancy
Thromboxane-A Synthase / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Methacrylates; 82571-53-7/ozagrel; EC 5.3.99.5/Thromboxane-A Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tumor necrosis factor alpha is elevated in the peritoneal fluid from women with ruptured ectopic pre...
Next Document:  Perinatal outcome in fetuses with loss of end-diastolic blood flow velocities in the descending aort...